114 related articles for article (PubMed ID: 37940428)
1. Radiomics Model for Predicting FOXP3 Expression Level and Survival in Clear Cell Renal Carcinoma.
Wang J; Huang Z; Zhou J
Acad Radiol; 2024 Apr; 31(4):1447-1459. PubMed ID: 37940428
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
He H; Jin Z; Dai J; Wang H; Sun J; Xu D
Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
[TBL] [Abstract][Full Text] [Related]
3. Radiomics Features on Enhanced Computed Tomography Predict FOXP3 Expression and Clinical Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
Wang Y; Ye J; Zhou K; Chen N; Huang G; Feng G; Zhang G; Gou X
J Imaging Inform Med; 2024 Feb; ():. PubMed ID: 38376584
[TBL] [Abstract][Full Text] [Related]
4. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Value of Radiomics Features Extracted From Computed Tomography in Patients With Localized Clear Cell Renal Cell Carcinoma After Nephrectomy.
Tang X; Pang T; Yan WF; Qian WL; Gong YL; Yang ZG
Front Oncol; 2021; 11():591502. PubMed ID: 33747910
[TBL] [Abstract][Full Text] [Related]
6. CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma.
Demirjian NL; Varghese BA; Cen SY; Hwang DH; Aron M; Siddiqui I; Fields BKK; Lei X; Yap FY; Rivas M; Reddy SS; Zahoor H; Liu DH; Desai M; Rhie SK; Gill IS; Duddalwar V
Eur Radiol; 2022 Apr; 32(4):2552-2563. PubMed ID: 34757449
[TBL] [Abstract][Full Text] [Related]
7. The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study.
Yang G; Nie P; Yan L; Zhang M; Wang Y; Zhao L; Li M; Xie F; Xie H; Li X; Xiang F; Wang N; Cheng N; Zhao X; Wang N; Wang Y; Chen C; Yun C; Cui J; Duan S; Zhang R; Hao D; Wang X; Wang Z; Niu H
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2949-2959. PubMed ID: 35344062
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
[TBL] [Abstract][Full Text] [Related]
9. A preoperative CT-based deep learning radiomics model in predicting the stage, size, grade and necrosis score and outcome in localized clear cell renal cell carcinoma: A multicenter study.
Nie P; Liu S; Zhou R; Li X; Zhi K; Wang Y; Dai Z; Zhao L; Wang N; Zhao X; Li X; Cheng N; Wang Y; Chen C; Xu Y; Yang G
Eur J Radiol; 2023 Sep; 166():111018. PubMed ID: 37562222
[TBL] [Abstract][Full Text] [Related]
10. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
11. Performance of CT radiomics in predicting the overall survival of patients with stage III clear cell renal carcinoma after radical nephrectomy.
Han D; Yu N; Yu Y; He T; Duan X
Radiol Med; 2022 Aug; 127(8):837-847. PubMed ID: 35834111
[TBL] [Abstract][Full Text] [Related]
12. Incremental value of radiomics with machine learning to the existing prognostic models for predicting outcome in renal cell carcinoma.
Xing J; Liu Y; Wang Z; Xu A; Su S; Shen S; Wang Z
Front Oncol; 2023; 13():1036734. PubMed ID: 37188171
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
14. MRI radiomics-based nomogram for individualised prediction of synchronous distant metastasis in patients with clear cell renal cell carcinoma.
Bai X; Huang Q; Zuo P; Zhang X; Yuan J; Zhang X; Wang M; Xu W; Ye H; Zhao J; Sun H; Shao B; Wang H
Eur Radiol; 2021 Feb; 31(2):1029-1042. PubMed ID: 32856163
[TBL] [Abstract][Full Text] [Related]
15. A multi-model based on radiogenomics and deep learning techniques associated with histological grade and survival in clear cell renal cell carcinoma.
Wang S; Zhu C; Jin Y; Yu H; Wu L; Zhang A; Wang B; Zhai J
Insights Imaging; 2023 Nov; 14(1):207. PubMed ID: 38010567
[TBL] [Abstract][Full Text] [Related]
16. A Computed Tomography-Based Radiomics Nomogram to Preoperatively Predict Tumor Necrosis in Patients With Clear Cell Renal Cell Carcinoma.
Jiang Y; Li W; Huang C; Tian C; Chen Q; Zeng X; Cao Y; Chen Y; Yang Y; Liu H; Bo Y; Luo C; Li Y; Zhang T; Wang R
Front Oncol; 2020; 10():592. PubMed ID: 32547934
[No Abstract] [Full Text] [Related]
17. Differentiation of Clear Cell and Non-clear-cell Renal Cell Carcinoma through CT-based Radiomics Models and Nomogram.
Cheng D; Abudikeranmu Y; Tuerdi B
Curr Med Imaging; 2023; 19(9):1005-1017. PubMed ID: 36411581
[TBL] [Abstract][Full Text] [Related]
18. Uncontrolled Confounders May Lead to False or Overvalued Radiomics Signature: A Proof of Concept Using Survival Analysis in a Multicenter Cohort of Kidney Cancer.
Lu L; Ahmed FS; Akin O; Luk L; Guo X; Yang H; Yoon J; Hakimi AA; Schwartz LH; Zhao B
Front Oncol; 2021; 11():638185. PubMed ID: 34123789
[TBL] [Abstract][Full Text] [Related]
19. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based CT radiomics approach for predicting WHO/ISUP nuclear grade of clear cell renal cell carcinoma: an exploratory and comparative study.
Xv Y; Lv F; Guo H; Zhou X; Tan H; Xiao M; Zheng Y
Insights Imaging; 2021 Nov; 12(1):170. PubMed ID: 34800179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
